ANET vs DHR: Which Is the Better Buy?
Side-by-side comparison of Arista Networks, Inc. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-24.
Arista Networks, Inc. · Technology
$203.47
+15.4% upside to fair value
Med Conviction
Grade C
High Quality
VS
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ANET |
DHR |
| Current Price |
$203.47 |
$221.12 |
| Fair Value Estimate |
$234.80 |
$286.52 |
| Upside to Fair Value |
+15.4%
|
+29.6%
|
| Market Cap |
$256.2B |
$155.4B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
49.7x
|
24.8x
|
| Price / Sales |
24.3x
|
6.2x
|
| Price / FCF |
49.7x
|
28.5x
|
| Revenue Growth YoY |
+37.7%
|
+5.5%
|
| Gross Margin |
63.0%
|
58.5%
|
| Operating Margin |
43.1%
|
20.4%
|
| Return on Equity |
30.8%
|
7.7%
|
| Dividend Yield |
0% |
0.65% |
| FCF Yield |
2.01%
|
3.51%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Arista Networks designs and sells high-performance Ethernet switching and routing hardware plus its extensible EOS network operating system, and it sits directly in the path of the AI data-center build-out where networking, not compute, is increasingly the bottleneck. The business quality is genuinely high: TTM gross margin of 63.0%, TTM operating margin of 43.1%, TTM net margin of 38.4%, and ROE…
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Accumulation Zones
| Metric |
ANET |
DHR |
| Zone Low |
$176.10 |
$214.89 |
| Zone High |
$199.58 |
$243.54 |
| In Buy Zone? |
No
|
Yes
|